Di Zeng
-
- MicroRNA in disease regulation 2
-
- Pluripotent Stem Cells Research 7
-
- Pharmacological Effects of Natural Compounds 3
-
- Tissue Engineering and Regenerative Medicine 6
- Cholangiocarcinoma and Gallbladder Cancer Studies 6
-
- 3D Printing in Biomedical Research 4
-
- Inflammatory Biomarkers in Disease Prognosis 3
- Pancreatic and Hepatic Oncology Research 2
- Partner nations
- ChinaUnited States
In The Last Decade
Di Zeng
29 papers receiving 455 citations
Peers
Comparison fields: 5 of 86
- Biomaterials 60
- Cancer Research 51
- Molecular Biology 212
- Pharmacology 26
- Pathology and Forensic Medicine 52
Countries citing papers authored by Di Zeng
This map shows the geographic impact of Di Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Di Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Di Zeng more than expected).
Fields of papers citing papers by Di Zeng
This network shows the impact of papers produced by Di Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Di Zeng. The network helps show where Di Zeng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Di Zeng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 4 | |
| 3 | 2025 | 4 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 3 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 0 | |
| 9 | 2023 | 35 | |
| 10 | 2022 | 6 | |
| 11 | 2021 | 17 | |
| 12 | 2021 | 12 | |
| 13 | 2020 | 43 | |
| 14 | 2020 | 18 | |
| 15 | 2016 | 31 | |
| 16 | 2015 | 48 | |
| 17 | 2015 | 7 | |
| 18 | 2013 | 13 | |
| 19 | 2013 | 34 | |
| 20 | 2011 | 38 |
About Di Zeng
Di Zeng is a scholar working on Aging, Pharmacology and Pathology and Forensic Medicine, having authored 33 papers that have together received 459 indexed citations. Recurring topics across this work include Pluripotent Stem Cells Research (7 papers), Tissue Engineering and Regenerative Medicine (6 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers), 3D Printing in Biomedical Research (4 papers), Pharmacological Effects of Natural Compounds (3 papers), Inflammatory Biomarkers in Disease Prognosis (3 papers), MicroRNA in disease regulation (2 papers) and Pancreatic and Hepatic Oncology Research (2 papers). The work is most often cited by research in Biomaterials (60 citations), Cancer Research (51 citations) and Molecular Biology (212 citations). Di Zeng has collaborated with scholars based in China and United States. Frequent co-authors include Xiongtao Liu, Qiangsun Zheng, Jianhua Ran, Ling Hu, Lisha Li, Guoli Li, Wenju Li, Shuang Zhao, Jing Li and Xiaoli Li.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.